Molecular pathogenesis and prognostic factors in endometrial carcinoma
- 1 October 2002
- Vol. 110 (10) , 673-689
- https://doi.org/10.1034/j.1600-0463.2002.1101001.x
Abstract
Endometrial carcinoma is today among the most common gynecologic malignancies in industrialized countries. In order to improve the treatment and follow‐up of these patients, various prognostic factor...Keywords
This publication has 168 references indexed in Scilit:
- Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinomaCancer, 2002
- Prognostic impact of morphometric nuclear grade of endometrial carcinomaCancer, 1998
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Mutant p53 protein as a predictor of survival in endometrial carcinomaEuropean Journal Of Cancer, 1996
- Hereditary cancer: Two hits revisitedZeitschrift für Krebsforschung und Klinische Onkologie, 1996
- Multivariate survival analysis of clinicopathologic features in surgical stage I endometrioid carcinoma including analysis of HER-2/neu expressionAmerican Journal of Obstetrics and Gynecology, 1995
- An analysis of approaches to the treatment of endometrial cancer in Western Europe: A CTF studyEuropean Journal Of Cancer, 1995
- Mutation and allelic loss of the p53 gene in endometrial carcinoma. Incidence and outcome in 92 surgical patientsCancer, 1995
- Biomarkers in the endometriumJournal of Cellular Biochemistry, 1995
- Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node SamplingGynecologic Oncology, 1995